| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.7M | — |
| Cost of Revenue | $124K | — |
| Gross Profit | $1.6M | — |
| R&D Expense | $1.8M | +1008.6% |
| SG&A Expense | $2.8M | +49.5% |
| Operating Income | -$3.5M | +30.9% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$3.5M | +58.4% |
| Income Tax | $0 | — |
| Net Income | -$3.0M | +66.6% |
| EPS (Basic) | -$0.04 | +87.1% |
| EPS (Diluted) | -$0.04 | +87.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $98K | +1273.5% |
| Accounts Receivable | $1.2M | — |
| Inventory | $404K | — |
| Current Assets | $2.5M | +686.8% |
| Total Assets | $2.8M | +550.5% |
| Current Liabilities | $5.8M | +444.3% |
| Total Liabilities | $5.8M | +444.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.6M | -109.4% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $2.7M | +21.6% |
| Stockholders' Equity |
| -$2.8M |
| -325.2% |